- Home
- STRO vs AIP Comparison
STRO vs AIP Comparison
Compare STRO & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- AIP
- Stock Information
- Founded
- STRO 2003
- AIP 2003
- Country
- STRO United States
- AIP United States
- Employees
- STRO N/A
- AIP N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- AIP Semiconductors
- Sector
- STRO Health Care
- AIP Technology
- Exchange
- STRO Nasdaq
- AIP Nasdaq
- Market Cap
- STRO 172.8M
- AIP 277.9M
- IPO Year
- STRO 2018
- AIP 2021
- Fundamental
- Price
- STRO $1.90
- AIP $10.22
- Analyst Decision
- STRO Strong Buy
- AIP Strong Buy
- Analyst Count
- STRO 7
- AIP 4
- Target Price
- STRO $12.14
- AIP $13.00
- AVG Volume (30 Days)
- STRO 1.4M
- AIP 242.4K
- Earning Date
- STRO 11-13-2024
- AIP 02-18-2025
- Dividend Yield
- STRO N/A
- AIP N/A
- EPS Growth
- STRO N/A
- AIP N/A
- EPS
- STRO N/A
- AIP N/A
- Revenue
- STRO $160,955,000.00
- AIP $54,739,000.00
- Revenue This Year
- STRO N/A
- AIP $8.13
- Revenue Next Year
- STRO N/A
- AIP $19.08
- P/E Ratio
- STRO N/A
- AIP N/A
- Revenue Growth
- STRO 230.90
- AIP 4.53
- 52 Week Low
- STRO $1.70
- AIP $4.83
- 52 Week High
- STRO $6.13
- AIP $10.60
- Technical
- Relative Strength Index (RSI)
- STRO 28.52
- AIP 60.68
- Support Level
- STRO $1.70
- AIP $8.72
- Resistance Level
- STRO $1.93
- AIP $10.35
- Average True Range (ATR)
- STRO 0.20
- AIP 0.58
- MACD
- STRO -0.01
- AIP -0.02
- Stochastic Oscillator
- STRO 12.60
- AIP 65.66
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About AIP Arteris Inc.
Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.